PRRT officially launched in NZ

Minister of Health, Hon Andrew Little, officially launched the new PRRT (Peptide Receptor Radionuclide Therapy) service for New Zealand neuroendocrine cancer patients on 14 July 2021.

In 2017, PHARMAC considered Unicorn Foundation NZ's PRRT funding submission. Concern at the continued delays in setting up PRRT led Unicorn Foundation to advocate for High Cost Treatment Pool funding.

In 2020 COVID-19 in Melbourne saw the Victorian state borders closed, so New Zealand NET patients could no longer access PRRT in Melbourne. Unicorn Foundation NZ was involved in the urgent work that followed to establish a permanent PRRT service at Auckland City Hospital — finally launched in 2021.

And now, we have PRRT as a permanent service for New Zealand patients.